# The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD

> **NCT05066633** · PHASE3 · RECRUITING · sponsor: **Medical University of Gdansk** · enrollment: 150 (estimated)

## Conditions studied

- Muscular Dystrophy, Duchenne

## Interventions

- **DRUG:** Metoprolol Succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05066633
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-18
- **Primary completion:** 2023-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066633, "The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05066633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*